17. PATIENT’S CHARACTERISTICS AND MANAGEMENT OF PREGNANT WOMEN WHO DIAGNOSED MILD AND MODERATE COVID-19 AT NATIONAL HOSPITAL OF OBSTETRICS AND GYNECOLOGY

Nguyen The Anh1, Nguyen Quang Bac2, Phan Thi Tinh2, Ngo Toan Anh2
1 Ha Tinh city General Hospital
2 National Hospital of Obstetrics and Gynecology

Main Article Content

Abstract

In 2022, pregnant women infected with COVID-19 were still a special concern for physicians at the National Hospital of Obstetrics and Gynecology.


Objective: To evaluate the treatment of pregnant women with mild and moderate COVID-19 at the National Hospital of Obstetrics and Gynecology from January 2022 to December 2022. Methodology: This is a cross-sectional study among pregnant women hospitalized with moderate and mild COVID-19 diagnoses.


Results: The rate of pregnant women with mild COVID-19 was 58.2%, moderate was 41.8%. The age group 25-29 had the highest incidence of COVID-19 in both study groups. The mean age in the mild COVID-19 group was 30.4±4.9 years and in the moderate COVID-19 group was 30.8±5.4 years. The average gestational age in the mild group at admission was 39.0±0.9 weeks and the moderate group was 39.0±1.0 weeks. The cesarean section rate in the mild COVID-19 group was 58.9% and in the moderate COVID-19 group was 41.1%.


Conclusion: The incidence of mild and moderate COVID-19 at the National Hospital of Obstetrics and Gynecology is comparable. For pregnant women with mild and moderate cases of COVID-19, the treatment method still prioritizes cesarean section.

Article Details

References

[1] Chen N, Zhou M, Dong X et al., Epidemiological
and clinical characteristics of 99 cases of
2019 novel coronavirus pneumonia in Wuhan,
China: a descriptive study. Lancet; Feb 15
2020;395(10223):507-513. doi:10.1016/s0140-
6736(20)30211-7
[2] Chen L, Li Q, Zheng D et al., Clinical
Characteristics of Pregnant Women with
Covid-19 in Wuhan, China; N Engl J Med,
Jun 18 2020;382(25):e100. doi:10.1056/
NEJMc2009226
[3] Sahin D, Tanacan A, Erol SA et al., Management
of pregnant women with COVID-19: A tertiary
pandemic center experience on 1416 cases; J Med
Virol, Mar 2022;94(3):1074-1084. doi:10.1002/
jmv.27423
[4] Siston AM, Rasmussen SA, Honein MA et
al., Pandemic 2009 influenza A(H1N1) virus
illness among pregnant women in the United
States; Jama, Apr 21 2010;303(15):1517-25.
doi:10.1001/jama.2010.479
[5] Prabhu M, Cagino K, Matthews KC et al.,
Pregnancy and postpartum outcomes in a
universally tested population for SARSCoV-2
in New York City: a prospective cohort
study; Bjog, Nov 2020;127(12):1548-1556.
doi:10.1111/1471-0528.16403
[6] Metz TD, Clifton RG, Hughes BL et al.,
Disease Severity and Perinatal Outcomes
of Pregnant Patients With Coronavirus
Disease 2019 (COVID-19); Obstet Gynecol,
Apr 1, 2021;137(4):571-580. doi:10.1097/
aog.0000000000004339
[7] Vousden N, Ramakrishnan R, Bunch K et
al., Management and implications of severe
COVID-19 in pregnancy in the UK: data from
the UK Obstetric Surveillance System national
cohort; Acta Obstet Gynecol Scand, Apr
2022;101(4):461-470. doi:10.1111/aogs.14329
[8] Eleje GU, Ugwu EO, Enebe JT et al., Cesarean
section rate and outcomes during and before
the first wave of COVID-19 pandemic; SAGE
Open Med, 2022;10:20503121221085453.
doi:10.1177/20503121221085453
[9] Liu S, Dzakpasu S, Nelson C et al., Pregnancy
Outcomes During the COVID-19 Pandemic
in Canada, March to August 2020; J Obstet
Gynaecol Can, Dec 2021;43(12):1406-1415.
doi:10.1016/j.jogc.2021.06.014
[10] Dumitriu D, Emeruwa UN, Hanft E et al.,
Outcomes of Neonates Born to Mothers With
Severe Acute Respiratory Syndrome Coronavirus
2 Infection at a Large Medical Center in New York
City; JAMA Pediatr, Feb 1, 2021;175(2):157-
167. doi:10.1001/jamapediatrics.2020.4298
[11] Conde-Agudelo A, Romero R, SARS-CoV-2
infection during pregnancy and risk of
preeclampsia: a systematic review and meta
analysis; Am J Obstet Gynecol, Jan 2022;
226(1):68-89.e3. doi:10.1016/j.ajog.2021.07.009
[12] Carlsen E, Magnus MC, Oakley L et al.,
Association of COVID-19 Vaccination During
Pregnancy With Incidence of SARS-CoV-2
Infection in Infants; JAMA Intern Med,
Aug 1, 2022;182(8):825-831. doi:10.1001/
jamainternmed.2022.2442